Jakob Loven - Net Worth and Insider Trading

Jakob Loven Net Worth

The estimated net worth of Jakob Loven is at least $45 Million dollars as of 2024-09-20. Jakob Loven is the Director of Arvinas Inc and owns about 1,694,351 shares of Arvinas Inc (ARVN) stock worth over $43 Million. Jakob Loven is also the Director of Kronos Bio Inc and owns about 1,301,537 shares of Kronos Bio Inc (KRON) stock worth over $1 Million. Details can be seen in Jakob Loven's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jakob Loven has not made any transactions after 2021-04-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jakob Loven

To

Jakob Loven Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jakob Loven owns 2 companies in total, including Kronos Bio Inc (KRON) , and Arvinas Inc (ARVN) .

Click here to see the complete history of Jakob Loven’s form 4 insider trades.

Insider Ownership Summary of Jakob Loven

Ticker Comapny Transaction Date Type of Owner
KRON Kronos Bio Inc 2021-04-20 director
ARVN Arvinas Inc 2018-10-01 director

Jakob Loven Latest Holdings Summary

Jakob Loven currently owns a total of 2 stocks. Among these stocks, Jakob Loven owns 1,694,351 shares of Arvinas Inc (ARVN) as of October 1, 2018, with a value of $43 Million and a weighting of 97.24%. Jakob Loven also owns 1,301,537 shares of Kronos Bio Inc (KRON) as of April 20, 2021, with a value of $1 Million and a weighting of 2.76%.

Latest Holdings of Jakob Loven

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARVN Arvinas Inc 2018-10-01 1,694,351 25.60 43,375,386
KRON Kronos Bio Inc 2021-04-20 1,301,537 0.95 1,233,206

Holding Weightings of Jakob Loven


Jakob Loven Form 4 Trading Tracker

According to the SEC Form 4 filings, Jakob Loven has made a total of 0 transactions in Arvinas Inc (ARVN) over the past 5 years. The most-recent trade in Arvinas Inc is the acquisition of 312,500 shares on October 1, 2018, which cost Jakob Loven around $5 Million.

According to the SEC Form 4 filings, Jakob Loven has made a total of 3 transactions in Kronos Bio Inc (KRON) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Kronos Bio Inc is the sale of 68,717 shares on April 20, 2021, which brought Jakob Loven around $1 Million.

Insider Trading History of Jakob Loven

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jakob Loven Trading Performance

GuruFocus tracks the stock performance after each of Jakob Loven's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jakob Loven is -19.74%. GuruFocus also compares Jakob Loven's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jakob Loven within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jakob Loven's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jakob Loven

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.68 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 12.98 LIMIT LIMIT LIMIT LIMIT LIMIT

Jakob Loven Ownership Network

Ownership Network List of Jakob Loven

No Data

Ownership Network Relation of Jakob Loven

Insider Network Chart

Jakob Loven Owned Company Details

What does Kronos Bio Inc do?

Who are the key executives at Kronos Bio Inc?

Jakob Loven is the director of Kronos Bio Inc. Other key executives at Kronos Bio Inc include director & 10 percent owner & President & CEO Norbert W Bischofberger , COO & General Counsel Barbara Kosacz , and Chief Scientific Officer Christopher Dinsmore .

Kronos Bio Inc (KRON) Insider Trades Summary

Over the past 18 months, Jakob Loven made no insider transaction in Kronos Bio Inc (KRON). Other recent insider transactions involving Kronos Bio Inc (KRON) include a net purchase of 5,351,696 shares made by Norbert W Bischofberger , a net sale of 40,194 shares made by Jorge Dimartino , and a net sale of 24,032 shares made by Christopher Dinsmore .

In summary, during the past 3 months, insiders sold 0 shares of Kronos Bio Inc (KRON) in total and bought 615,518 shares, with a net purchase of 615,518 shares. During the past 18 months, 116,028 shares of Kronos Bio Inc (KRON) were sold and 5,351,696 shares were bought by its insiders, resulting in a net purchase of 5,235,668 shares.

Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kronos Bio Inc Insider Transactions

No Available Data

Jakob Loven Mailing Address

Above is the net worth, insider trading, and ownership report for Jakob Loven. You might contact Jakob Loven via mailing address: C/o Arvinas, Inc., 5 Science Park, 395 Winchester Avenue, New Haven Ct 06511.

Discussions on Jakob Loven

No discussions yet.